Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.41 |
| ▸ | DPP4 | P27487 | 5/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | FAP | Q12884 | 1/20 | 0.34 |
| ▸ | PITRM1 | Q5JRX3 | 1/20 | 0.34 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.34 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.34 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL27686097 | 1.00 | PKM (0.44) | PKMHSD11B1DPP4ALDH1A1GAA | |
| Methacrylic Acid SCHEMBL209644 | 0.88 | THRB (0.36) | PKMHSD11B1ALDH1A1NPC1 | |
| Methacrylic Acid SCHEMBL21924975 | 0.88 | THRB (0.36) | PKMHSD11B1ALDH1A1NPC1 | |
| Methacrylic Acid SCHEMBL5355469 | 0.82 | PKM (0.34) | PKMHSD11B1DPP4ALDH1A1DPP8 | |
| Methacrylic Acid SCHEMBL28713508 | 0.81 | L3MBTL1 (0.34) | PKMHSD11B1DPP4ALDH1A1FAP | |
| Methacrylic Acid SCHEMBL27410214 | 0.80 | TSHR (0.46) | ALDH1A1GAA | |
| SCHEMBL587576 | 0.79 | HSD11B1 (0.49) | PKMHSD11B1ALDH1A1 | |
| Methacrylic Acid SCHEMBL29283555 | 0.78 | ALDH1A1 (0.53) | PKMALDH1A1GAA | |
| Methacrylic Acid SCHEMBL10615031 | 0.78 | KMT2A (0.38) | ALDH1A1GAANPC1 | |
| SCHEMBL28361569 | 0.78 | PKM (0.36) | PKMHSD11B1DPP4ALDH1A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117659263-A | Weather-resistant room-temperature-degradable water-soluble photosensitive resin, application and preparation method thereof | 中国地质大学（武汉） | 2024-03-08 | — | — | CN | claimed |
| US-11576998-B2 | High refractive index, high Abbe number intraocular lens materials | ALCON INC. (CH) | 2023-02-14 | — | — | US | claimed |
| CN-110730673-B | High refractive index, high Abbe number intraocular lens materials | 爱尔康公司 | 2022-04-19 | — | — | CN | claimed |
| EP-3634508-B1 | HIGH REFRACTIVE INDEX, HIGH ABBE NUMBER INTRAOCULAR LENS MATERIALS | ALCON INC (CH) | 2021-10-27 | — | — | EP | claimed |
| US-20200292730-A1 | HIGH REFRACTIVE INDEX, HIGH ABBE NUMBER INTRAOCULAR LENS MATERIALS | ALCON RESEARCH, LTD. | 2020-09-17 | — | — | US | claimed |
| US-10712474-B2 | High refractive index, high abbe number intraocular lens materials | ALCON INC. (CH) | 2020-07-14 | — | — | US | claimed |
| CN-110730673-A | High refractive index, high Abbe number intraocular lens materials | 爱尔康公司 | 2020-01-24 | — | — | CN | claimed |
| US-20190339419-A1 | HIGH REFRACTIVE INDEX, HIGH ABBE NUMBER INTRAOCULAR LENS MATERIALS | ALCON INC. (CH) | 2019-11-07 | — | — | US | claimed |
| US-20180348404-A1 | HIGH REFRACTIVE INDEX, HIGH ABBE NUMBER INTRAOCULAR LENS MATERIALS | ALCON INC. (CH) | 2018-12-06 | — | — | US | claimed |
| US-20260110823-A1 | OPTICAL ELEMENT, OPTICAL APPARATUS, IMAGING APPARATUS, AND COMPOUND | CANON KK (JP) | 2026-04-23 | — | — | US | disclosed |
| EP-4696722-A1 | (METH)ACRYLATE, CURABLE COMPOSITION, CURED BODY, LAMINATE, OPTICAL ARTICLE, LENS, AND EYEGLASSES | TOKUYAMA CORPORATION (JP) | 2026-02-18 | — | — | EP | disclosed |
| US-12529822-B2 | Optical element, optical apparatus, imaging apparatus, and compound | CANON KABUSHIKI KAISHA (JP) | 2026-01-20 | — | — | US | disclosed |
| US-12479976-B2 | Cured product, optical element, optical apparatus, and imaging apparatus | CANON KABUSHIKI KAISHA (JP) | 2025-11-25 | — | — | US | disclosed |
| EP-4644435-A1 | URETHANE (METH)ACRYLATE, CURABLE COMPOSITION, CURED BODY, LAMINATE, OPTICAL ARTICLE, LENSES, AND EYEGLASSES | TOKUYAMA CORPORATION (JP) | 2025-11-05 | — | — | EP | disclosed |
| EP-2390684-A2 | Optical element compound, optical material, and optical element | Canon Kabushiki Kaisha (JP) | 2011-11-30 | — | — | EP | disclosed |
| US-20110288330-A1 | OPTICAL ELEMENT COMPOUND, OPTICAL MATERIAL, AND OPTICAL ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2011-11-24 | — | — | US | disclosed |
| US-20110257146-A1 | Method of Treating Kcnq Related Disorders Using Organozinc Compounds | THE JOHNS HOPKINS UNIVERSITY (US) | 2011-10-20 | — | — | US | disclosed |
| WO-2011081078-A1 | HETEROAROMATIC-CONTAINING COMPOUND, OPTICAL MATERIAL AND OPTICAL ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2011-07-07 | — | — | WO | disclosed |
| US-20100022733-A1 | (METH)ACRYLATE COPOLYMER FOR SYRUP AND RESIN COMPOSITION THEREOF | IDEMITSU KOSAN CO., LTD. (JP) | 2010-01-28 | — | — | US | disclosed |
| EP-2088164-A1 | (METH)ACRYLATE COPOLYMER FOR SYRUP AND RESIN COMPOSITION THEREOF | Idemitsu Kosan Co., Ltd. (JP) | 2009-08-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260110823-A1 | OPTICAL ELEMENT, OPTICAL APPARATUS, IMAGING APPARATUS, AND COMPOUND | RAD51, PIEZO1, ZYX | PKM 3991/4885HSD11B1 2962/4885DPP4 3075/4885 |
| US-12529822-B2 | Optical element, optical apparatus, imaging apparatus, and compound | RAD51, SEM1, PSMA3 | PKM 3923/4885HSD11B1 2979/4885DPP4 2763/4885 |
| US-20110257146-A1 | Method of Treating Kcnq Related Disorders Using Organozinc Compounds | KCNQ3, KCNQ1, KCNQ5 | PKM 234/4885HSD11B1 2168/4885DPP4 169/4885 |
| US-20110288330-A1 | OPTICAL ELEMENT COMPOUND, OPTICAL MATERIAL, AND OPTICAL ELEMENT | CENPE, AXIN2, CCNE2 | PKM 2719/4885HSD11B1 1317/4885DPP4 3251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.